Results 161 to 170 of about 1,040,958 (268)
The context-dependent role of group 2 innate lymphoid cells in lung diseases. [PDF]
Chen Y, Ji X, Qiu J, Qiu J.
europepmc +1 more source
The relationship between triglyceride-glucose index and chronic lung diseases: a nationwide cohort study. [PDF]
Li Y, Wu Y, Lei L, Jiang Z, Duan M.
europepmc +1 more source
Immune Checkpoint Inhibitor–Related Myositis and Associated Triad Overlap Syndrome
Objective Immune checkpoint inhibitor (ICI) myositis is a rare but a highly morbid condition, particularly with the ICI myositis triad syndrome of myositis, myocarditis, and myasthenia gravis. We report the clinical characteristics of ICI myositis and all‐cause mortality in these patients.
Selene Rubino +9 more
wiley +1 more source
Association between frailty and chronic lung diseases in middle aged and older population. [PDF]
Zhou D +10 more
europepmc +1 more source
Rheumatologic Manifestations of Patients With Type B Insulin Resistance
Objective The objectives of this study were to identify laboratory and clinical features associated with type B insulin resistance (TBIR), a rare condition caused by autoantibodies that inhibit the insulin receptor, most frequently occurring in the setting of systemic lupus erythematosus (SLE), and to increase awareness of this rare, life‐threatening ...
S. Amara Ogbonnaya +4 more
wiley +1 more source
Pulmonary hypertension associated with nonparenchymal restrictive lung diseases. [PDF]
Jutant EM +4 more
europepmc +1 more source
Objective The aim of this study was to determine the differences in demographic, serologic, and clinical characteristics between male and female patients with systemic sclerosis (SSc) in an Australian cohort. Methods This was a retrospective observational study using data from the Australian Scleroderma Cohort Study.
Emily Lin +14 more
wiley +1 more source
Precision Medicine Advances in Chronic Lung Diseases. [PDF]
Bakakos A +4 more
europepmc +1 more source
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos +2 more
wiley +1 more source
Refractory Lung Diseases: From Cellular Structures, Molecular Mechanisms to Therapeutic Strategies. [PDF]
Qiu Y +12 more
europepmc +1 more source

